Taken together, the above analyses support the utility of the phenocopy score in identifying TP53-associated drug sensitivity or resistance, and also support that our tumor-derived classifier is able to generalize to cancer cell line transcriptomes to detect a phenotype of functional TP53 loss. Here, TP53 is linked to cancer.